Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102127135B reveals a mild gold-catalyzed glycosylation method for nucleoside intermediates, offering superior regioselectivity and cost reduction in pharmaceutical manufacturing.